Last update 08 May 2025

HSV1-tk PET imaging agent (JW PHARMACEUTICAL)

Overview

Basic Info

Drug Type
Small molecule drug, Diagnostic radiopharmaceuticals
Synonyms
cis-1-[4-(Hydroxymethyl)-2-cyclopenten-1-yl]-5-[124I]iodouracil
Target
TK
Action
modulators
Mechanism
thymidine kinase modulators(Thymidine kinase modulators)
Therapeutic Areas
Infectious DiseasesSkin and Musculoskeletal Diseases
Active Indication-
Inactive Indication
Herpes Simplex
Originator Organization
JW PHARMACEUTICAL Corp.JW PHARMACEUTICAL Corp.
Active Organization-
Inactive Organization
JW PHARMACEUTICAL Corp.JW PHARMACEUTICAL Corp.
License Organization-
Drug Highest PhasePendingDiscovery
First Approval Date-
Regulation-

Structure/Sequence

Molecular FormulaC10H11IN2O3
InChIKeyFIGOIHRJINUHNT-AEQHHNBMSA-N
CAS Registry960286-37-7

Related

100 Clinical Results associated with HSV1-tk PET imaging agent (JW PHARMACEUTICAL)
Login to view more data
100 Translational Medicine associated with HSV1-tk PET imaging agent (JW PHARMACEUTICAL)
Login to view more data
100 Patents (Medical) associated with HSV1-tk PET imaging agent (JW PHARMACEUTICAL)
Login to view more data
1
Literatures (Medical) associated with HSV1-tk PET imaging agent (JW PHARMACEUTICAL)
01 Nov 2007Journal of Medicinal ChemistryQ1 · MEDICINE
Synthesis and Evaluation of cis-1-[4-(Hydroxymethyl)-2-cyclopenten-1-yl]-5-[124I]iodouracil:  A New Potential PET Imaging Agent for HSV1-tk Expression
Q1 · MEDICINE
100 Deals associated with HSV1-tk PET imaging agent (JW PHARMACEUTICAL)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Herpes SimplexDiscovery
South Korea
JW PHARMACEUTICAL Corp.JW PHARMACEUTICAL Corp.
26 Oct 2007
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free